Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5538_Библиотеки_им_академика_М_И_Перельмана
.pdf
116 Substance Use in Older Adults
RESOURCES FOR PATIENTS, FAMILIES,
AND CAREGIVERS
Taking Medicines Safely as You Age: The National Institute on Ag-
ing website includes helpful information for older adults related
edication safety, including a worksheet for keeping track of
to m
medications (www.nia.nih.gov/health/taking-medicines-safelyyou-age; in Spanish: www.nia.nih.gov/espanol/adultos-mayoresuso-seguro-medicamentos; worksheet: www.nia.nih.gov/sites/
default/files/2021-06/worksheet-medications.pdf).
U.S. Deprescribing Research Network: A variety of resources are
availa
ble for patients and caregivers regarding research on depre-
scribing (https://deprescribingresearch.org/for-patients/).
RESOURCES FOR CLINICIANS
Conduct Brown Bag Medicine Reviews: Tool #8 (www.ahrq.gov/
health-literacy/improve/precautions/tool8.html): The Agency
for Healthc
practices conduct medicine reconciliation using information in the
medical record or as reported by the patient, a Brown Bag Medicine Review is more thorough” (Health Literacy Universal Precautions Toolkit, 2nd Edition), available at: https://ahrq.gov/
health-literacy/improve/precautions/toolkit.html). This website
provides details instructions for health care professionals and
clinics on how to implement these reviews.
Deprescribing Guidelines and Algorithms (https://deprescrib-
ing.org/resources/deprescribing-guidelines-algorithms): This
website includes depr
Bruyère Research Institute in Ontario, Canada, for five medication
classes: antipsychotics, benzodiazepine receptor agonists, cognitive enhancers (cholinesterase inhibitors and memantine), antihyperg
Benzo Basics (https://taperology.web.app): This website provides
re
sources for clinicians for deprescribing benzodiazepines and patient education materials on the use of benzodiazepines. It was
crea
ted by Dr. Donovan Maust as a part of a project funded by the
National Institute on Drug Abuse.
are Research and Quality notes that “although many
escribing algorithms developed by the
lycemics, and proton-pump inhibitors.
Safe Prescribing Practices for Older Adults 117
REFERENCES
Accreditation Canada: Medication reconciliation as a strategic priority, in Re-
quired Organizational Practices 2020 Handbook. Ontario, Canada, Accreditation Canada, 2020, pp 19–20
Agency for Healthcare Research and Quality: Patient Safety Primer: Medication
ministration Errors. Washington, DC, Agency for Healthcare Research
Ad
and Quality, 2019. Available at: https://psnet.ahrq.gov/primer/
medication-administration-errors. Accessed August 31, 2022.
Aira M, Hartikainen S, Sulkava R: Drinking alcohol for medicinal purposes by
le aged over 75: a community-based interview study. Fam Pract
peop
25(6):445–449, 2008 18826990
American Geriatrics Society Beers Criteria Update Expert Panel: American
Geriatrics Socie
priate medication use in older adults. J Am Geriatr Soc 71(7):2052–2081,
2023 37139824
Arana GW, Epstein S, Molloy M, et al: Carbamazepine-induced reduction of
plasma alprazolam
49(11):448–449, 1988 3182735
Ates Bulut E, Isik AT: Abuse/misuse of prescription medications in older
adults. Clin Geriatr Med 38(1):85–97, 2022 34794705
Béland SG, Préville M, Dubois MF, et al: The association between length of ben-
zodiaz
epine use and sleep quality in older population. Int J Geriatr Psychi-
atry 26(9):908–915, 2011 20963787
Berna C, Kulich RJ, Rathmell JP: Tapering long-term opioid therapy in chronic
noncanc
Mayo Clin Proc 90(6):828–842, 2015 26046416
Bessey LJ, Walaszek A: Management of behavioral and psychological symp-
toms of dementia. Curr Psychiatry Rep 21(8):66, 2019 31264056
Beuscart JB, Pelayo S, Robert L, et al: Medication review and reconciliation in
older adults. Eur Geriatr Med 12(3):499–507, 2021 33583002
Bjerre LM, Farrell B, Hogel M, et al: Deprescribing antipsychotics for behavioural
and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Can Fam Physician 64(1):17–27, 2018 29358245
Bohnert ASB, Ilgen MA: Understanding links among opioid use, overdose, and
suicide. N Engl J Med 380(1):71–79, 2019
Bolla KI, Brown K, Eldreth D, et al: Dose-related neurocognitive effects of mar-
ijuana use. Neurology 59(9):1337–1343, 2002 12427880
Borrelli F, Capasso R, Izzo AA: Garlic (Allium sativum L.): adverse effects and drug
interactions in humans. Mol Nutr Food Res 51(11):1386–1397, 2007 17918162
Briscoe J, Casarett D: Medical marijuana use in older adults. J Am Geriatr Soc
66(5):859–863, 2018 29668039
Bush DM: Emergency Department Visits for Drug Misuse or Abuse Involving
the Pain Medication Tramadol. Rockville, MD, Center for Behavioral
Health Statistics and Quality, SAMHSA, 2013. Available at: https://
www.samhsa.gov/data/sites/default/files/report_1966/ShortReport-
1966.html. Accessed August 31, 2022.
ty 2023 updated AGS Beers Criteria for potentially inappro-
concentrations: a clinical case report. J Clin Psychiatry
er pain: evidence and recommendations for everyday practice.
118 Substance Use in Older Adults
Centers for Disease Control and Prevention: Pocket Guide: Tapering Opioids
for Chronic Pain. Atlanta, GA, Centers for Disease Control and Prevention,
2016. Available at: https://www.cdc.gov/drugoverdose/pdf/
clinical_pocket_guide_tapering-a.pdf. Accessed August 21, 2022.
Centers for Disease Control and Prevention: Wide-ranging online data for epi-
demiologic re
and Prevention, 2022. Available at: https://wonder.cdc.gov/wonder/
help/main.html. Accessed August 31, 2022.
Cheatle MD, Savage SR: Informed consent in opioid therapy: a potential obligation
and opportunity. J Pain Symptom Manage 44(1):105–116, 2012 22445273
Chen LH, Hedegaard H, Warner M: Drug-poisoning deaths involving opioid anal-
gesics: United States, 1999–2011. NCHS Data Brief (166):1–8, 2014 25228059
Chen XW, Serag ES, Sneed KB, et al: Clinical herbal interactions with conven-
tional drugs: from molecules to maladies. Curr Med Chem 18(31):4836–
4850, 2011 21919844
Colliver JD, Compton WM, Gfroerer JC, et al: Projecting drug use among aging
boomers in 2020. Ann Epidemiol 16(4):257–265, 2006 16275134
baby
Corsonello A, Onder G, Abbatecola AM, et al: Explicit criteria for potentially in-
appropriate medications to reduce the risk of adverse drug reactions in elderly people: from Beers to STOPP/START criteria. Drug Saf 35(Suppl
1):21–28, 2012 23446783
Dassanayake T, Michie P, Carter G, et al: Effects of benzodiazepines, antide-
pressants and opioids on driving: a systematic review and meta-analysis of
epidem
21247221
de Souza Silva JE, Santos Souza CA, da Silva TB, et al: Use of herbal medicines
by elderly pa
233, 2014 25063588
Dowell D, Haegerich TM, Chou R: CDC guideline for prescribing opioids for
nic pain—United States, 2016. MMWR Recomm Rep 65(1):1–49, 2016
chro
26987082
English BA, Dortch M, Ereshefsky L, Jhee S: Clinically significant psychotropic
drug–drug interactions in the primary care setting. Curr Psychiatry Rep
14(4):376–390, 2012 22707017
Fleishaker JC, Hulst LK: A pharmacokinetic and pharmacodynamic evaluation
of the combined administratio
Pharmacol 46(1):35–39, 1994 8005185
Frank JW, Lovejoy TI, Becker WC, et al: Patient outcomes in dose reduction or
discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med 167(3):181–191, 2017 28715848
Fried TR, O’Leary J, Towle V, et al: Health outcomes associated with polyphar-
macy in community-dwelling older adults: a systematic review. J Am Geriatr Soc 62(12):2261–2272, 2014 25516023
Gannon JM, Lupu A, Brar J, et al: Deprescribing anticholinergic medication in
the com
Social Adm Pharm 17(10):1841–1846, 2021 33357980
Gatchel RJ, McGeary DD, McGeary CA, et al: Interdisciplinary chronic pain
management: past, present, and future. Am Psychol 69(2):119–130, 2014
24547798
search (WONDER). Atlanta, GA, Centers for Disease Control
iological and experimental evidence. Drug Saf 34(2):125–156, 2011
tients: a systematic review. Arch Gerontol Geriatr 59(2):227–
n of alprazolam and fluvoxamine. Eur J Clin
munity mental health setting: a quality improvement initiative. Res
Safe Prescribing Practices for Older Adults 119
Gelot S, Nakhla E: Opioid dosing in renal and hepatic impairment. US Pharm
39(8):34–38, 2014
Glare P, Ashton-James C, Han E, Nicholas M: Deprescribing long-term opioid
therapy in patients with chro
33111411
Growdon ME, Gan S, Yaffe K, Steinman MA: Polypharmacy among older adults
with deme
J Am Geriatr Soc 69(9):2464–2475, 2021 34101822
Gupta S, Cahill J, Miller R: Deprescribing benzodiazepines, z-drugs, and stim-
ulants, in Deprescribing in Psychiatry. Edited by Gupta S, Miller R, Cahill
J. New York, Oxford University Press, 2019, pp 199–216
Hallvik SE, El Ibrahimi S, Johnston K, et al: Patient outcomes after opioid dose
re
duction among patients with chronic opioid therapy. Pain 163(1):83–90,
2022 33863865
Han BH, Palamar JJ: Trends in cannabis use among older adults in the United
States, 2015–2018. JAM
32091531
Hanlon JT, Schmader KE, Samsa GP, et al: A method for assessing drug therapy
appropriate
Herget G: Methadone and buprenorphine added to the WHO list of essential
medicines. HIV AIDS
Herrmann N, Ismail Z, Collins R, et al: CCCDTD5 recommendations on the de-
pre
8(1):e12099, 2022
The Joint Commission: 2022 National Patient Safety Goals. Oakbrook Terrace,
IL, The Joint Commission,
commission.org/standards/national-patient-safety-goals. Accessed
August 25, 2022.
Jones CM, Mack KA, Paulozzi LJ: Pharmaceutical overdose deaths, United
States, 2010. JAMA
Joshi P, Shah NK, Kirane HD: Medication-assisted treatment for opioid use dis-
order in older adults: an emerging role for the geriatric psychiatrist. Am J
Geriatr Psychiatry 27(4):455–457, 2019 30718033
Kaiser RM: Physiological and clinical considerations of geriatric patient care, in
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 5th
Edition. Edited by Steffens DC, Blazer DG, Thakur MR. Washington, DC,
American Psychiatric Publishing, 2015, pp 33–60
Karp JF, Butters MA, Begley AE, et al: Safety, tolerability, and clinical effect of
low-dose buprenorphine for treatment-resistant depression in midlife and
older adults. J Clin Psychiatry 75(8):e785–e793, 2014 25191915
Kua CH, Mak VSL, Huey Lee SW: Health outcomes of deprescribing interven-
tions among older residents in nursing homes: a systematic review and
meta-analysis. J Am Med Dir Assoc 20(3):362–372, 2019 30581126
Leelakanok N, Holcombe AL, Lund BC, et al: Association between polyphar-
macy and death: a systematic review and meta-analysis. J Am Pharm Assoc
(2003) 57(6):729–738, 2017
Levi-Minzi MA, Surratt HL, Kurtz SP, et al: Under treatment of pain: a prescrip-
tion for opioid misuse among the elderly? Pain Med 14(11):1719–1729, 2013
23841571
ntia compared with those without dementia in the United States.
ness. J Clin Epidemiol 45(10):1045–1051, 1992 1474400
scribing of cognitive enhancers in dementia. Alzheimers Dement (N Y)
309(7):657–659, 2013 23423407
nic pain. Intern Med J 50(10):1185–1191, 2020
A Intern Med 180(4):609–611, 2020
Policy Law Rev 10(3):23–24, 2005 16544403
2022. Available at: https://www.joint
120 Substance Use in Older Adults
Lynch T, Price A: The effect of cytochrome P450 metabolism on drug response,
interactions, and adverse effects. Am Fam Physician 76(3):391–396, 2007
17708140
Macintyre PE, Huxtable CA: Buprenorphine for the management of acute pain.
sth Intensive Care 45(2):143–146, 2017 28267934
Anae
Mandrioli R, Mercolini L, Raggi MA: Metabolism of benzodiazepine and non-
benz
odiazepine anxiolytic-hypnotic drugs: an analytical point of view.
Curr Drug Metab 11(9):815–829, 2010 21189133
Masnoon N, Shakib S, Kalisch-Ellett L, et al: What is polypharmacy? A system-
atic review of definitions. BMC Geriatr 17(1):230, 2017 29017448
Maust DT, Kales HC, Wiechers IR, et al: No end in sight: benzodiazepine use in
older adults in the United States. J Am Geriatr Soc 64(12):2546–2553, 2016
27879984
Maust DT, Strominger J, Kim HM, et al: Prevalence of central nervous system-
active polypharmacy amon
325(10):952–961, 2021 33687462
Meehan KM, Wang H, David SR, et al: Comparison of rapidly acting intramus-
cular olanzapine, lorazepam, and placebo: a double-blind, randomized
study in acutely agitated patients with dementia. Neuropsychopharmacology 26(4):494–504, 2002 11927174
Morin CM, Bastien C, Guay B, et al: Randomized clinical trial of supervised ta-
pering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry
161(2):33
Naples JG, Gellad WF, Hanlon JT: The role of opioid analgesics in geriatric pain
management. Clin Geriatr Med 32(
National Center for Health Statistics: Health, United States, 2018. Hyattsville,
MD, National Center for Health Statistics, 2019. Available at: https://
www.cdc.gov/nchs/data/hus/hus18.pdf. Accessed June 9, 2023.
National Health Services Grampian: Guidance for Prescribing and Withdrawal
of Benzodiazepines and Hypnotics in General Practice. Grampian, Scotland, National Health Services Grampian, 2008. Available at: https://
www.benzo.org.uk/amisc/bzgrampian.pdf. Accessed August 21,
2022.
Nicolussi S, Drewe J, Butterweck V, Meyer Zu Schwabedissen HE: Clinical rel-
evance of St. John’s wort drug interactions revisited. Br J Pharmacol
177(6):1212–1226, 2020 31742659
O’Mahony D, O’Sullivan D, Byrne S, et al: STOPP/START criteria for poten-
tially inappropriate prescribing in older people: version 2. Age Ageing
44(2):213–
Otto MW, Pollack MH, Sabatino SA: Maintenance of remission following cog-
nitive behavior therapy for panic disorder: possible deleterious effects of
concurrent medication treatment. Behav Ther 27:473–482, 1996
Paquin AM, Zimmerman K, Rudolph JL: Risk versus risk: a review of benzodi-
azepine reduction in older adults. Expert Opin Drug Saf 13(7):919–934,
2014 24905348
Pazan F, Wehling M: Polypharmacy in older adults: a narrative review of defi-
nitions, epidemiology and consequences. Eur Geriatr Med 12(3):443–452,
2021 33694123
2–342, 2004 14754783
218, 2015 25324330
g older adults with dementia in the US. JAMA
4):725–735, 2016 27741966
Safe Prescribing Practices for Older Adults 121
Pergolizzi J, Böger RH, Budd K, et al: Opioids and the management of chronic
severe pain in the elderly: consensus statement of an International Expert
Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 8(4):287–313, 2008 18503626
Pottie K, Thompson W, Davies S, et al: Deprescribing benzodiazepine receptor
agonists: evidence-based clinical practice guideline. Can Fam Physician
64(5):339–351, 2018 29760253
Pourbaix S, Desager JP, Hulhoven R, et al: Pharmacokinetic consequences of
long te
rm coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects. Int J Clin Pharmacol Ther Toxicol 23(8):447–451, 1985 2864320
Qato DM, Wilder J, Schumm LP, et al: Changes in prescription and over-the-
nter medication and dietary supplement use among older adults in the
cou
United States, 2005 vs. 2011. JAMA Intern Med 176(4):473–482, 2016
26998708
Rankin A, Cadogan CA, Patterson SM, et al: Interventions to improve the ap-
propriate use of polypharmacy for older people. Cochrane Database Syst
Rev 9(9
):CD008165, 2018 30175841
Redmond P, Grimes TC, McDonnell R, et al: Impact of medication reconcilia-
tion for improving transitions of care. Cochrane Database Syst Rev
8(8):CD010791, 2018 30136718
Reeve E: Deprescribing tools: a review of the types of tools available to aid de-
prescribing in clinical pra
Reeve E, Gnjidic D, Long J, et al: A systematic review of the emerging definition
of “depr
and clinical practice. Br J Clin Pharmacol 80(6):1254–1268, 2015 27006985
Rizos EC, Ntzani EE, Bika E, et al: Association between omega-3 fatty acid sup-
plementation and risk of major cardiovascular disease events: a systematic
review and meta-analysis. JAMA 308(10):1024–1033, 2012 22968891
Rochon PA, Gurwitz JH: Optimising drug treatment for elderly people: the pre-
scribing cascade. BMJ 315(7115):1096–1099, 1997 9366745
Rosenberg JM, Bilka BM, Wilson SM, Spevak C: Opioid therapy for chronic
pain: overview of the 2017 US Department of Veterans Affairs and US Department of Defense clinical practice guideline. Pain Med 19(5):928–941,
2018 29025128
Rothbaum BO, Price M, Jovanovic T, et al: A randomized, double-blind evalu-
ation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War
veterans. Am J Psychiatry 171(6):640–648, 2014 24743802
Rummans TA, Burton MC, Dawson NL: How good intentions contributed to
bad o
29502564
Samara EE, Granneman RG, Witt GF, et al: Effect of valproate on the pharmaco-
kine
450, 1997 9156377
Schifano F, Chiappini S, Miuli A, et al: Focus on over-the-counter drugs’ misuse:
a systematic review on antihistamines, cough medicines, and decongestants. Front Psychiatry 12:657397, 2021 34025478
escribing” with network analysis: implications for future research
utcomes: the opioid crisis. Mayo Clin Proc 93(3):344–350, 2018
tics and pharmacodynamics of lorazepam. J Clin Pharmacol 37(5):442–
ctice. J Pharm Pract Res 50(1):98–107, 2020
122 Substance Use in Older Adults
Simoni-Wastila L, Yang HK: Psychoactive drug abuse in older adults. Am J
Geriatr Pharmacother 4(4):380–394, 2006 17296542
Sites BD, Beach ML, Davis MA: Increases in the use of prescription opioid anal-
gesics and the lack of improvement in disability metrics among users. Reg
th Pain Med 39(1):6–12, 2014 24310049
Anes
Slattum PW, Ogbonna KC, Peron EP: The pharmacology of aging, in Brockle-
hurst’s
Textbook of Geriatric Medicine and Gerontology, 8th Edition. Edited by Fillit HM, Rookwood K, Young J. Philadelphia, PA, Elsevier, 2017,
pp 160–165
S
oldatos CR, Dikeos DG, Whitehead A: Tolerance and rebound insomnia with
rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
Int Clin Psychopharmacol 14(5):287–303, 1999 10529072
Sponsler KC, Neal EB, Kripalani S: Improving medication safety during hospi-
tal-based transitions of care. Cleve Clin J Med 82(6):351–360, 2015 26086494
Substance Abuse and Mental Health Services Administration (SAMHSA):
2019 NSDUH Detailed Tables. Rockville, MD, Substance Abuse and
Mental Health Services Administration, 2020. Available at https://
www.samhsa.gov/data/report/2019-nsduh-detailed-tables. Accessed
August 31, 202
Sun EC, Dixit A, Humphreys K, et al: Association between concurrent use of
prescription o
analysis. BMJ 356:j760, 2017 28292769
Tadrous M, Shakeri A, Chu C, et al: Assessment of stimulant use and cardiovas-
cular event risks among older adults. JAMA Netw Open 4(10):e2130795,
2021 34694389
Tannenbaum C, Martin P, Tamblyn R, et al: Reduction of inappropriate benzo-
diazepine
tion: the EMPOWER cluster randomized trial. JAMA Intern Med
174(6):89
U.S. Food and Drug Administration: FDA warns about serious risks and death
when combining opioid pain and cough medicines with benzodiazepines;
requires its strongest warning. FDA Drug Safety Communication, August
31, 2016. Available at: http://www.fda.gov/Drugs/DrugSafety/
ucm518473.htm. Accessed August 31, 2022.
U.S. Food and Drug Administration: FDA urges caution about withholding opi-
oid addiction medications from patients taking benzodiazepines or CNS
depr
essants: careful medication management can reduce risks. FDA Drug
Safety Communication, September 20, 2017. Available at: https://
www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safetycommunication-fda-urges-caution-about-withholding-opioid-addictionmedications. Accessed August 31, 2022.
Washington State Agency Medical Directors’ Group: Interagency guideline on
prescribing opioids for pain. Olympia, WA, Washington State Agency
Medical Directors’ Group, 2015. Available at: https://amdg.wa.gov/Files/
2015AMDG
OpioidGuideline.pdf. Accessed August 21, 2022.
Wastesson JW, Morin L, Tan ECK, et al: An update on the clinical consequences
of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf
17(12):1185–1196, 2018 30540223
2
pioids and benzodiazepines and overdose: retrospective
prescriptions among older adults through direct patient educa-
0–898, 2014 24733354
Safe Prescribing Practices for Older Adults 123
Weiss BD, Brega AG, LeBlanc WG, et al: Improving the effectiveness of medica-
tion review: guidance from the Health Literacy Universal Precautions Toolkit. J Am Board Fam Med 29(1):18–23, 2016 26769873
Wie che rs I R, L esl ie DL, R osenheck RA: Prescribing of psychotropic medications
to patients
1248, 2013 23999894
Woodward MC: Deprescribing: achieving better health outcomes for older peo-
ple through reducing medications. J Pharm Pract Res 33(4):323–328, 2003
World Health Organization: Medication Safety in Polypharmacy. Geneva,
Switzerland, W
apps.who.int/iris/bitstream/handle/10665/325454/WHO-UHC-SDS-
2019.11-eng.pdf?ua=1. Accessed August 26, 2022.
World Health Organization: WHO Model List of Essential Medications.
Geneva, Switzerland, Wo
https://www.who.int/groups/expert-committee-on-selection-and-useof-essential-medicines/essential-medicines-lists. Accessed January 11,
2024.
without a psychiatric diagnosis. Psychiatr Serv 64(12):1243–
orld Health Organization, 2019. Available at: https://
rld Health Organization, 2023. Available at:
CHAPTER 5
Alcohol Use and
Use Disorder Among
Older Adults
Ganesh Gopalakrishna, M.D., M.H.A.
Pallavi Joshi, D.O., M.A.
Nisha Patel, D.O.
Alcohol is the most commonly used and misused substance among
older adults. Although incidence levels are lower than among younger
adults, there is an upward trend in the number of older people consuming alcohol and meeting criteria for alcohol use disorder (AUD). Stigma
about alcohol use from families and clinicians can serve as an obstacle
in identifying and treating AUDs. Good pharmacological and psychosocial treatments are available for older adults, with outcomes similar
to those of younger adults. In this chapter, we describe the various alcohol misuse terminology, epidemiology of alcohol use, and AUD. We
125
Соседние файлы в папке Библиотека им академика М.И. Перельмана